MedPath

Georgetown University

Georgetown University logo
🇬🇹Guatemala
Ownership
Private
Established
1789-01-23
Employees
5K
Market Cap
-
Website
http://www.georgetown.edu

Sunitinib and Capecitabine for First Line Colon Cancer

Phase 2
Terminated
Conditions
Metastatic Colorectal Cancer
Interventions
First Posted Date
2009-08-19
Last Posted Date
2025-02-12
Lead Sponsor
Georgetown University
Target Recruit Count
50
Registration Number
NCT00961571
Locations
🇺🇸

Lombardi Cancer Center at Georgetown University, Washington, District of Columbia, United States

Testing of Computer Aided Detection Software for Riverain Medical Group

Completed
Conditions
Lung Cancer
Interventions
Behavioral: Software
First Posted Date
2009-05-21
Last Posted Date
2014-09-01
Lead Sponsor
Georgetown University
Target Recruit Count
15
Registration Number
NCT00906789
Locations
🇺🇸

ISIS Imaging Science Research Center, Georgetown University, Washington, District of Columbia, United States

Low Dose Cyclosporin and Methotrexate Therapy in Diabetes

Not Applicable
Completed
Conditions
Type 1 Diabetes Mellitus
Interventions
First Posted Date
2009-05-20
Last Posted Date
2011-04-13
Lead Sponsor
Georgetown University
Target Recruit Count
8
Registration Number
NCT00905073
Locations
🇺🇸

Georgetown University, Washington DC, District of Columbia, United States

Gene Expression in Tumor Tissue From Women Undergoing Surgery for Breast Cancer or Core Biopsy of the Breast

Terminated
Conditions
Breast Cancer
First Posted Date
2009-05-12
Last Posted Date
2018-04-13
Lead Sponsor
Georgetown University
Target Recruit Count
55
Registration Number
NCT00898937
Locations
🇺🇸

Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington, District of Columbia, United States

Lapatinib and Capecitabine for Second Line Treatment of Pancreas Cancer

Phase 2
Terminated
Conditions
Pancreas Cancer
Interventions
First Posted Date
2009-04-15
Last Posted Date
2025-03-03
Lead Sponsor
Georgetown University
Target Recruit Count
17
Registration Number
NCT00881621
Locations
🇺🇸

Georgetown University Medical Center, Washington, District of Columbia, United States

Study Using Pharmacogenetics to Select Treatment for Head and Neck Cancer

Phase 2
Withdrawn
Conditions
Head and Neck Cancer
Interventions
First Posted Date
2009-04-15
Last Posted Date
2015-03-27
Lead Sponsor
Georgetown University
Registration Number
NCT00881114

A Study of FOLFOX6 With Bevacizumab for Biliary System Carcinoma

Phase 2
Terminated
Conditions
Biliary Tract Cancer
Interventions
Drug: "Bevacizumab" in combination with "modified FOLFOX6".
First Posted Date
2009-04-15
Last Posted Date
2014-10-20
Lead Sponsor
Georgetown University
Target Recruit Count
9
Registration Number
NCT00881504
Locations
🇺🇸

Georgetown University Medical Center, Washington, District of Columbia, United States

Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)

Phase 1
Completed
Conditions
Non-Hodgkin's Lymphoma
Chronic Lymphocytic Leukemia
Interventions
Drug: BLR-CLL
Drug: BLR-NHL
Drug: BL-NHL
First Posted Date
2009-03-19
Last Posted Date
2015-03-13
Lead Sponsor
Georgetown University
Target Recruit Count
28
Registration Number
NCT00864942
Locations
🇺🇸

Georgetown University Hospital/Lombardi Cancer Center, Washington, District of Columbia, United States

Study of Pemetrexed for Second-Line Pancreas Cancer

Phase 2
Terminated
Conditions
Pancreas Cancer
Interventions
First Posted Date
2009-03-18
Last Posted Date
2015-12-08
Lead Sponsor
Georgetown University
Target Recruit Count
17
Registration Number
NCT00864513
Locations
🇺🇸

Georgetown University Hospital/Lombardi Cancer Center, Washington, District of Columbia, United States

Lenalidomide Following Fludarabine/Rituximab (FR) in Untreated Chronic Lymphocytic Leukemia (CLL)

Phase 2
Completed
Conditions
Chronic Lymphocytic Leukemia
Interventions
First Posted Date
2009-03-12
Last Posted Date
2018-11-21
Lead Sponsor
Georgetown University
Target Recruit Count
22
Registration Number
NCT00860457
Locations
🇺🇸

Lombardi Cancer Center at Georgetown University Medical Center, Washington, District of Columbia, United States

© Copyright 2025. All Rights Reserved by MedPath